Should angiotensin converting enzyme (ACE) inhibitors be used routinely after infarction? Perspectives from the Survival and Ventricular Enlargement (SAVE) trial.
- 1 February 1994
- Vol. 71 (2) , 115-118
- https://doi.org/10.1136/hrt.71.2.115
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Effects of early captopril administration on infarct expansion, left ventricular remodeling and exercise capacity after acute myocardial infarctionThe American Journal of Cardiology, 1991
- Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertensionThe American Journal of Cardiology, 1991
- Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II — DAVIT II)The American Journal of Cardiology, 1990
- Effect of Captopril on Progressive Ventricular Dilatation after Anterior Myocardial InfarctionNew England Journal of Medicine, 1988
- Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarctionThe American Journal of Cardiology, 1986
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985
- Risk Stratification and Survival after Myocardial InfarctionNew England Journal of Medicine, 1983
- The stunned myocardium: prolonged, postischemic ventricular dysfunction.Circulation, 1982
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations.Circulation, 1979